BodyGuard Microset with Male Luer Connectors, REF: A100-163XEBF

FDA Device Recall #Z-2581-2020 — Class I — June 16, 2020

Recall Summary

Recall Number Z-2581-2020
Classification Class I — Serious risk
Date Initiated June 16, 2020
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm CME America, LLC
Location Golden, CO
Product Type Devices
Quantity 8016

Product Description

BodyGuard Microset with Male Luer Connectors, REF: A100-163XEBF

Reason for Recall

Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy

Distribution Pattern

U.S: CA, IN, LA, MO, FL, IL, ME, MN, CO, VA, OK, NE, GA, AL, KY, IA, MS, ID, TX, SC, OH, SD, NV, MI, WY, NC, PA, TN, KS, NJ, OR, AR, NM, MA, NY, DC, RI, MD, WA, WI, AZ, NH, UT, HI, AK, MT, ND, VT, CT. OUS (Foreign): Canada, UK

Lot / Code Information

All lots within expiry

Other Recalls from CME America, LLC

Recall # Classification Product Date
Z-0530-2021 Class II CME America T-Syringe Pump - T34 - Product Usag... Jul 30, 2020
Z-0529-2021 Class II CME America T-Syringe Pump - Ameritus 1st Enter... Jul 30, 2020
Z-0528-2021 Class II CME America T-Syringe Pump - Neofeed - Product ... Jul 30, 2020
Z-0527-2021 Class II CME America T-Syringe Pump - T34L PCA - Product... Jul 30, 2020
Z-0526-2021 Class II CME America T-Syringe Pump - NeoThrive - Produc... Jul 30, 2020

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.